- Home
- /
- Treatment
- /
- Page 29
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
S-ethylisothiourea diethylphosphate | Symptomatic intradialytic hypotension, including symptomatic hypotension in the immediate post-dialytic period | TrioxBio, Inc.;P. O. Box 1000;Wilmington, Delaware, 19801 | August 29, 2016 |
|
Synthetic ribonucleic acid oligonucleotide directed against superoxide dismutase 1 messenger ribonucleic acid | Amyotrophic lateral sclerosis | Biogen Idec Limited | August 29, 2016 |
|
131-I-8H9 monoclonal antibody | Neuroblastoma | Memorial Sloan Kettering Cancer Center;1275 York Avenue;New York, New York, 10065 | August 29, 2016 |
|
Temozolomide | Glioma | Double Bond Pharmaceutical AB | August 29, 2016 |
|
2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-alpha]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile | Idiopathic pulmonary fibrosis | Galapagos NV | August 29, 2016 |
|
Zoledronic acid | Glioma | Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A. | August 29, 2016 |
|
Anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single domain antibody | Pancreatic Cancer | Singh Biotechnology, LLC;4708 Rue Bordeaux;Lutz, Florida, 33558 | August 29, 2016 |
|
2-(1,5-dimethyl-3-phenyl-1H-pyrrol-2-yl)-N-{4-[4-(5-fluoro-pyrimidin-2-yl)piperazin-1-yl]-phenyl}-2-oxo-acetamide | Scedosporiosis | F2G Ltd | August 29, 2016 |
|
Adenovirus associated viral vector serotype 5 containing the humanRPGRgene | Retinitis pigmentosa | MeiraGTx UK II Limited | August 29, 2016 |
|
Autologous mesenchymal stromal cells on a decellularised tracheal scaffold from a cadaveric donor | Tracheal stenosis | Videregen Ltd | August 29, 2016 |
|
Cannabidiol | Graft Versus Host Disease | Richardson Associates Regulatory Affairs Ltd | August 29, 2016 |
|
Cisplatin | Malignant pleural mesothelioma | PlumeStars s.r.l. | August 29, 2016 |
|
Ublituximab | Neuromyelitis optica | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 25, 2016 |
|
Recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1) | Primary sclerosing cholangitis | Acorda Therapeutics, Inc.;420 Saw Mill River Road;Ardsley, New York, 10502 | August 25, 2016 |
|
Phosphoinositide-3-kinase delta inhibitor | Chronic lymphocytic leukemia | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 | August 23, 2016 |
|
Rituximab and recombinant human hyaluronidase | Chronic lymphocytic leukemia | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 |
|
Recombinant human interleukin-12 | Acute Radiation Syndrome Acute radiation syndrome | Neumedicines, Inc.;133 Altadena Drive, Suite 133;Pasadena, California, 91107 | August 22, 2016 |
|
Rituximab and recombinant human hyaluronidase | Follicular lymphoma | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | August 22, 2016 |
|
Etrolizumab | Ulcerative colitis | Genentech, Inc.;1 Dna Way;South San Francisco, California, 94080 | August 22, 2016 |
|
Nivolumab | Esophageal cancer | Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492 | August 22, 2016 |
|
Cultured skin substitute (CSS) | Burns requiring skin grafting | Regenicin Inc.;10 High Court;Little Falls, New Jersey, 07424 | August 22, 2016 |
|
(1,3)-�-D-glucan synthesis inhibitor | Invasive Aspergillus infections | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 | August 22, 2016 |
|
Disufenton sodium | Glioblastoma | Oblato, Inc.;116 Village Boulevard;Princeton, New Jersey, 08540 | August 22, 2016 |
|
(1,3)-ß-D-glucan synthesis inhibitor | Invasive Aspergillus infections | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 | August 22, 2016 |
|
Live E. coli Nissle bacterium modified to assimilate ammonia | Urea cycle disorders | Synlogic, Inc.;200 Sidney Street, #320;Cambridge, Massachusetts, 02139 | August 22, 2016 |
